USANA HEALTH SCIENCES, INC. Interest Expense Nonoperating
USANA HEALTH SCIENCES, INC. (USNA) reported Interest Expense Nonoperating of $0 for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for the quarter ending 2026-07-04 was $0.00, a 100.00% decline year-over-year.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for the quarter ending 2026-04-04 was $240.00K, a 41.61% decline year-over-year.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for the quarter ending 2026-01-03 was $123.00K, a 4.65% decline year-over-year.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for the quarter ending 2025-09-27 was $49.00K, a 0.00% change year-over-year.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for fiscal 2026 was $842.00K, a 199.64% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for fiscal 2024 was $281.00K, a 7.25% increase from fiscal 2023.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for fiscal 2023 was $262.00K, a 36.46% increase from fiscal 2022.
- USANA HEALTH SCIENCES, INC. interest expense nonoperating for fiscal 2022 was $192.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-07-04 | $0.00 10-Q · filed 2026-08-13 | $240.00K 10-Q · filed 2026-08-13 | $363.00K derived: sum of 3 quarters · filed 2026-08-13 | $412.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | $240.00K 10-Q · filed 2026-05-12 | $363.00K derived: sum of 2 quarters · filed 2026-05-12 | $412.00K derived: sum of 3 quarters · filed 2026-05-12 | $671.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $123.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $172.00K derived: sum of 2 quarters · filed 2026-03-16 | $431.00K derived: sum of 3 quarters · filed 2026-08-13 | $842.00K 10-K · filed 2026-03-16 |
| 2025-09-27 | $49.00K 10-Q · filed 2025-11-05 | $308.00K derived: sum of 2 quarters · filed 2026-08-13 | $719.00K 10-Q · filed 2025-11-05 | $848.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $259.00K 10-Q · filed 2026-08-13 | $670.00K 10-Q · filed 2026-08-13 | $799.00K derived: sum of 3 quarters · filed 2026-08-13 | $848.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | $411.00K 10-Q · filed 2026-05-12 | $540.00K derived: sum of 2 quarters · filed 2026-05-12 | $589.00K derived: sum of 3 quarters · filed 2026-05-12 | $640.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $178.00K derived: sum of 2 quarters · filed 2026-03-16 | $229.00K derived: sum of 3 quarters · filed 2026-03-16 | $281.00K 10-K · filed 2026-03-16 |
| 2024-09-28 | $49.00K 10-Q · filed 2025-11-05 | $100.00K derived: sum of 2 quarters · filed 2025-11-05 | $152.00K 10-Q · filed 2025-11-05 | $297.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-29 | $51.00K 10-Q · filed 2025-08-05 | $103.00K 10-Q · filed 2025-08-05 | $248.00K derived: sum of 3 quarters · filed 2026-03-16 | $291.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-30 | $52.00K 10-Q · filed 2025-05-06 | $197.00K derived: sum of 2 quarters · filed 2026-03-16 | $240.00K derived: sum of 3 quarters · filed 2026-03-16 | $283.00K derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-30 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $188.00K derived: sum of 2 quarters · filed 2026-03-16 | $231.00K derived: sum of 3 quarters · filed 2026-03-16 | $262.00K 10-K · filed 2026-03-16 |
| 2023-09-30 | $43.00K 10-Q · filed 2024-11-05 | $86.00K derived: sum of 2 quarters · filed 2024-11-05 | $117.00K 10-Q · filed 2024-11-05 | |
| 2023-07-01 | $43.00K 10-Q · filed 2024-08-06 | $74.00K 10-Q · filed 2024-08-06 | ||
| 2022-12-31 | $192.00K 10-K · filed 2025-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |